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Abstract
The kisspeptin receptor (nomenclature as agreed by the NC-IUPHAR Subcommittee on the kisspeptin
receptor [9]), like neuropeptide FF (NPFF), prolactin-releasing peptide (PrP) and QRFP receptors (provisional
nomenclature) responds to endogenous peptides with an arginine-phenylalanine-amide (RFamide) motif.
kisspeptin-54 (KP54, originally named metastin), kisspeptin-13 (KP13) and kisspeptin-10 (KP10) are biologically-
active peptides cleaved from the KISS1 (Q15726) gene product. Kisspeptins have roles in, for example, cancer
metastasis, fertility/puberty regulation and glucose homeostasis.
Contents
This is a citation summary for Kisspeptin receptor in the Guide to Pharmacology database (GtoPdb). It exists
purely as an adjunct to the database to facilitate the recognition of citations to and from the database by citation
analyzers. Readers will almost certainly want to visit the relevant sections of the database which are given here
under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current





Introduction to Kisspeptin receptor
http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=34
    Receptors
            kisspeptin receptor
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=266
1
References
1. Becker JA, Mirjolet JF, Bernard J, Burgeon E, Simons MJ, Vassart G, Parmentier M and Libert F. (2005)
Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific
transcriptional program not shared by other Gq-coupled receptors. Biochem. Biophys. Res. Commun. 326:
677-86 [PMID:15596153]
2. Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, Zoratti C, Malli R, Sharabi A, Hiden U and
Graier W et al.. (2004) Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion
inhibitor of primary human trophoblasts. J. Cell. Sci. 117: 1319-28 [PMID:15020672]
3. Clements MK, McDonald TP, Wang R, Xie G, O'Dowd BF, George SR, Austin CP and Liu Q. (2001)
FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54.
Biochem. Biophys. Res. Commun. 284: 1189-93 [PMID:11414709]
4. Curtis AE, Cooke JH, Baxter JE, Parkinson JR, Bataveljic A, Ghatei MA, Bloom SR and Murphy KG.
(2010) A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am. J. Physiol.
Endocrinol. Metab. 298: E296-303 [PMID:19934405]
5. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL and Milgrom E. (2003) Hypogonadotropic
hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci.
U.S.A. 100: 10972-6 [PMID:12944565]
6. Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, Yang S, Monsma FJ and
Gustafson EL. (2003) The KiSS-1 receptor GPR54 is essential for the development of the murine
reproductive system. Biochem. Biophys. Res. Commun. 312: 1357-63 [PMID:14652023]
7. Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T, Shintani Y, Yamada T, Suenaga M and Kitada
C et al.. (2001) Metastin suppresses the motility and growth of CHO cells transfected with its receptor.
Biochem. Biophys. Res. Commun. 286: 958-63 [PMID:11527393]
8. Irwig MS, Fraley GS, Smith JT, Acohido BV, Popa SM, Cunningham MJ, Gottsch ML, Clifton DK and
Steiner RA. (2004) Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of
KiSS-1 mRNA in the male rat. Neuroendocrinology 80: 264-72 [PMID:15665556]
9. Kirby HR, Maguire JJ, Colledge WH and Davenport AP. (2010) International Union of Basic and Clinical
Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function. Pharmacol. Rev. 62:
565-78 [PMID:21079036]
10. Kobayashi T, Sasaki S, Tomita N, Fukui S, Nakayama M, Kiba A, Kusaka M, Matsumoto S, Yamaguchi M
and Itoh F et al.. (2010) 2-acylamino-4,6-diphenylpyridine derivatives as novel GPR54 antagonists with
good brain exposure and in vivo efficacy for plasma LH level in male rats. Bioorg. Med. Chem. 18: 5157-71
[PMID:20580563]
11. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S,
Tyldesley R, Suarez-Huerta N and Vandeput F et al.. (2001) The metastasis suppressor gene KiSS-1
encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem.
276: 34631-6 [PMID:11457843]
12. Lee DK, Nguyen T, O'Neill GP, Cheng R, Liu Y, Howard AD, Coulombe N, Tan CP, Tang-Nguyen AT and
George SR et al.. (1999) Discovery of a receptor related to the galanin receptors. FEBS Lett. 446: 103-7
[PMID:10100623]
13. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE and Welch DR. (1996) KiSS-1, a novel
human malignant melanoma metastasis-suppressor gene. J. Natl. Cancer Inst. 88: 1731-7 [PMID:8944003]
14. Masui T, Doi R, Mori T, Toyoda E, Koizumi M, Kami K, Ito D, Peiper SC, Broach JR and Oishi S et al..
(2004) Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem. Biophys.
Res. Commun. 315: 85-92 [PMID:15013429]
15. Mead EJ, Maguire JJ, Kuc RE and Davenport AP. (2007) Kisspeptins are novel potent vasoconstrictors in
humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-
prone vessels. Endocrinology 148: 140-7 [PMID:17023533]
16. Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J, Thresher RR, Malinge I, Lomet D and
Carlton MB et al.. (2005) Kisspeptin directly stimulates gonadotropin-releasing hormone release via G
2
protein-coupled receptor 54. Proc. Natl. Acad. Sci. U.S.A. 102: 1761-6 [PMID:15665093]
17. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM,
Chambers JK and Murdock P et al.. (2001) AXOR12, a novel human G protein-coupled receptor, activated
by the peptide KiSS-1. J. Biol. Chem. 276: 28969-75 [PMID:11387329]
18. Navarro VM, Castellano JM, Fernández-Fernández R, Tovar S, Roa J, Mayen A, Barreiro ML, Casanueva
FF, Aguilar E and Dieguez C et al.. (2005) Effects of KiSS-1 peptide, the natural ligand of GPR54, on
follicle-stimulating hormone secretion in the rat. Endocrinology 146: 1689-97 [PMID:15637288]
19. Navarro VM, Castellano JM, Fernández-Fernández R, Tovar S, Roa J, Mayen A, Nogueiras R, Vazquez
MJ, Barreiro ML and Magni P et al.. (2005) Characterization of the potent luteinizing hormone-releasing
activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 146: 156-63 [PMID:15375028]
20. Navarro VM, Fernández-Fernández R, Castellano JM, Roa J, Mayen A, Barreiro ML, Gaytan F, Aguilar E,
Pinilla L and Dieguez C et al.. (2004) Advanced vaginal opening and precocious activation of the
reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J. Physiol. (Lond.) 561: 379-86
[PMID:15486019]
21. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y and
Masuda Y et al.. (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-
coupled receptor. Nature 411: 613-7 [PMID:11385580]
22. Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD and Saji M. (2002) Metastin receptor
is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J. Clin.
Endocrinol. Metab. 87: 2399 [PMID:11994395]
23. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J, Pineda R, Gottsch
ML, Tena-Sempere M and Moenter SM et al.. (2009) Discovery of potent kisspeptin antagonists delineate
physiological mechanisms of gonadotropin regulation. J. Neurosci. 29: 3920-9 [PMID:19321788]
24. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno Jr JS, Shagoury JK, Bo-Abbas Y,
Kuohung W, Schwinof KM and Hendrick AG et al.. (2003) The GPR54 gene as a regulator of puberty. N.
Engl. J. Med. 349: 1614-27 [PMID:14573733]
25. Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, O'rahilly S and Aparicio SA.
(2005) Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic
hypogonadism. J. Clin. Endocrinol. Metab. 90: 1849-55 [PMID:15598687]
26. Stafford LJ, Xia C, Ma W, Cai Y and Liu M. (2002) Identification and characterization of mouse metastasis-
suppressor KiSS1 and its G-protein-coupled receptor. Cancer Res. 62: 5399-404 [PMID:12359743]
27. Tomita K, Oishi S, Ohno H and Fujii N. (2008) Structure-activity relationship study and NMR analysis of
fluorobenzoyl pentapeptide GPR54 agonists. Biopolymers 90: 503-11 [PMID:18302161]
28. West A, Vojta PJ, Welch DR and Weissman BE. (1998) Chromosome localization and genomic structure
of the KiSS-1 metastasis suppressor gene (KISS1). Genomics 54: 145-8 [PMID:9806840]
29. Xing R, Liu F, Yang Y, Cui X, Wang T, Xie L, Zhao Y, Fang L, Yi T and Zheng B et al.. (2018) GPR54
deficiency reduces the Treg population and aggravates experimental autoimmune encephalomyelitis in
mice. Sci China Life Sci 61: 675-687 [PMID:29931449]
3
